诺司咪唑对小鼠致畸性的研究

目的：观察抗组织胺新药诺司咪唑对小鼠的致畸作用。方法：在小鼠妊娠致畸敏感期(6—15天)分别连续灌胃给予诺司咪唑29．2、58．4和116．8mg／kg，于妊娠第18天解剖动物并记录孕鼠体重、活胎数、死胎数、吸收胎数、胎仔体重、身长、尾长、胎盘重及外观、骨骼和内脏畸形胎仔数。结果：诺司咪唑使孕鼠体重生长缓慢，但对生殖能力无明显影响，高剂量组对胎仔体重、身长和尾长有一定影响，各组均未见胎仔有外观、骨骼和内脏畸形。结论：诺司咪唑对胎仔发育有一定影响，但无致畸作用。     

抗癌胶囊对实验性肿瘤的治疗及对化疗减毒作用研究

目的：研究抗癌胶囊对小鼠移植肿瘤S180，H22，Lewis的抑瘤作用及对化疗药所致小鼠免疫功能抑制的保护作用。方法：按照抗癌药物筛选规程进行体内抑瘤实验：采用氟尿嘧啶（FU）制备免疫功能低下模型，测定抗癌胶囊对小鼠白细胞计数、免疫器官重量、腹腔巨噬细胞吞噬功能和NK细胞的影响。结果：抗癌胶囊对小鼠移植肿瘤S180，H22，Lewis均有不同的抑瘤作用，其中高剂量组抑瘤效果最佳，并对小鼠体重生长无明显影响。抗癌胶囊还有明显拮抗FU所致白细胞下降，胸腺、脾脏萎缩，腹腔巨噬细胞功能降低和NK细胞减少等毒副作用。结论：抗癌胶囊具有明显的抗肿瘤作用。     

香菇多糖对巨噬细胞一氧化氮和一氧化氮合酶活性的影响

目的研究香菇多糖(LTN)诱导巨噬细胞的一氧化氮(NO)生成和一氧化氮合酶(iNOS)的活性,探讨LTN的免疫调节作用机理.方法采用Griess反应和荧光法测定不同剂量的LTN作用小鼠腹腔巨噬细胞后NO的生成量和iNOS活性.观察mRNA转录抑制剂、蛋白质合成抑制剂和iNOS抑制剂对巨噬细胞NO的生成和iNOS活性的影响.结果LTN能使小鼠腹腔巨噬细胞NO生成增加,iNOS活性增高,并呈作用剂量依赖关系.3种抑制剂均能抑制LTN诱导的小鼠腹腔巨噬细胞N0的生成和iNOS活性.结论LTN能刺激小鼠腹腔巨噬细胞提高iNOS活性和NO的生成.提示LTN的免疫调节作用机制可能与LTN刺激巨噬细胞NO生成有关.     

慢性肺源性心脏病患者动脉血PaCO2与血清胃泌素水平及幽门螺杆菌的关系

目的了解慢性肺源性心脏病(简称肺心病)患者PaCO2与血清胃泌素水平及幽门螺杆菌的关系,探讨肺心病合并上消化道出血的原因。方法观察组肺心病患者44例均符合1977年全国肺心病会议制定的诊断标准。对照组42例为随机选取的健康成人,两组性别、年龄无差异。PaCO2由本院血气分析室用nova-3型仪器测定,同时测定患者血清胃泌素,由首都医科大学临床检测中心运用放射免疫方法专人测定,用C13呼气实验(C-UBT)检测幽门螺杆菌的感染情况。全部数据以均值±标准差表示(x±s),均数差别显著性以t检验及逐步回归测算确定PaCO2与血清胃泌素及幽门螺杆菌的关系。结果肺心病组与对照组PaCO2、血清胃泌素及幽门螺杆菌两组对照有极显著性差异(P<0.001)。结论肺心病患者血清胃泌素水平较正常人明显升高,且幽门螺杆菌的感染率明显升高,与PaCO2呈正相关,易于并发上消化道出血。     

电子病历书写的质量管理与对策

目的 探讨和总结电子病历（Eleetronic Medical Record,EMR)使用中医生记录的质量控制方法。方法 对EMR中医生记录进行质量分析，找出存在的常见主观性和客观性错误，采用软件设计与建立管理制度的方法提高质量。结果 通过改进软件设计和建立健全规章制度可以达到EMR质量控制。     

化学诱导大鼠多发肾囊肿伴肾肿瘤及肾组织DNA损伤的表达

目的 观察化学药物大鼠多发肾囊肿伴肾肿瘤模型的诱发情况和ＤＮＡ损伤标记物８－羟基脱氧鸟苷（８－ＯＨｄＧ）在其肾组织的表达。方法 用２－氨基４,５－二苯噻唑（ＤＰＴ）和Ｎ－亚硝基吗啉（ＮＮＭ）诱发和人类获得性肾囊肿（ＡＣＤＫ）伴肾癌相似的大鼠动物模型,并用免疫组化方法（ＬＳＡＢ法）检查８－ＯＨｄＧ在大鼠肾组织的表达。结果在本实验中,ＮＮＭ组３／１０的大鼠诱发肾肿瘤出现,在ＤＰＴ／ＮＮＭ组的９只大鼠均     

Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors.

Genomic sequences of the human polyomaviruses, JC virus (JCV) and BK virus (BKV), and simian virus 40 (SV40) have been reported from several types of human brain tumors, but there have been no population-based seroepidemiologic studies to evaluate the association between polyomavirus infection and brain tumors. We conducted a case-control study, nested within a prospective cohort, to investigate the association between antibodies to JCV, BKV, and SV40, as measured in serum collected 1-22 years before diagnosis and incident primary malignant brain tumors. Brain tumor cases (n = 44) and age-, gender-, and race-matched controls (n = 88) were identified from participants of two specimen banks in Washington County, Maryland. IgG antibodies to the capsid proteins of JCV and BKV were assessed using ELISAs. SV40-neutralizing antibodies were measured using plaque neutralization assays. Similar to the general population, the prevalence of JCV and BKV infection was high in our study population (77 and 85%, respectively). Antibodies to SV40 were less prevalent (11%). The odds ratio for subsequent brain tumor development was 1.46 [95% confidence interval (CI), 0.61-3.5] for JCV, 0.66 for BKV (95% CI, 0.22-1.95), and 1.00 for SV40 (95% CI, 0.30-3.32). Given the high prevalence of JCV and BKV infections and the millions who were potentially exposed to SV40 through contaminated polio vaccines, future studies should attempt to replicate these findings.     

Survival and developmental disability in infants with birth weights of 501 to 800 grams, born between 1979 and 1994

OBJECTIVE: Because the survival rate has increased for extremely low birth weight neonates, many have raised the concern that the rate of developmental disability among survivors will also increase. To address this concern, we analyzed changes over time in survival and major neurosensory impairment in a sample of extremely low birth weight infants born between July 1, 1979, and June 30, 1994. METHODS: The study sample included 513 infants with birth weights of 501 to 800 g who were cared for in either of the two neonatal intensive care units that serve a 17-county region in northwest North Carolina and who were born to mothers residing in that region. At 1 year of age (corrected for gestation), survivors were examined by a pediatrician and were tested using the Bayley Scales of Infant Development. Major neurosensory impairment was defined as cerebral palsy, a Bayley Mental Developmental Index <68, or blindness. A total of 209/216 (97%) of survivors were examined at 1 year of age. Epoch of birth was defined as follows: epoch 1, July 1, 1979 to June 30, 1984; epoch 2, July 1, 1984 to June 30, 1989; and epoch 3, July 1, 1989 to June 30, 1994. RESULTS: Survival rates for epochs 1, 2, and 3 were, respectively, 24/120 (20%), 63/175 (36%), and 129/218 (59%). In contrast, the proportions with a major neurosensory impairment did not increase over time; rates for successive epochs were 6/24 (25%), 17/61 (28%), and 26/124 (21%). Rates of cerebral palsy were 3/24 (13%), 12/61 (20%), and 9/124 (7%); rates of delayed mental development were 4/24 (17%), 12/61 (20%), and 17/124 (14%); and rates of blindness were 2/24 (8%), 0/62, and 5/124 (4%), respectively. CONCLUSIONS: This analysis suggests that the increasing survival of extremely low birth weight neonates since the late 1970s has not resulted in an increased rate of major developmental problems identifiable at 1 year of age.     

STUDIES OF THE CHARACTERISTIC FEATURES OF KI-1 POSITIVE NON-HODGKIN'S LYMPHOMA

Ki-lantigen(CD3o)waslO5oOo/12oooOglycoproteindistinguishedbymonoclonalantibodyKi-lwhichwasmadefromHodgkin'sdisease(HD)cellsstrainL-428,'eXPressedonHDcellsandReed-Sternberg(R-S)cellsatfirstthoughtItwasfoundbySteinandothersinl985,whonamedKi-lstrongpositiveNHLasKi-llymphoma,thatKi-lantigenwasalsoexpressedonsomeNHL.2Theresearchesonthisspecialtypeoflymphomahavealreadyappearedabroad.WehavecollectedfivecasesofKi-lpositiveNHLandnowdiscusstheirclinicalhistopathologicalandimmunophenotypicfe…     

御感速袋泡剂质量标准的研究

御感速袋泡剂按新药审评标准进行了质量标准的研究，鉴别项下除建立了显微方法外还建立了柴胡皂甙ａ，ｄ，连翘甙，葛根素，青蒿的薄层鉴别方法。用ＨＰＬＣ对黄芩甙和葛根素进行了含量测定。